Page 5 - Cosmetics Rules News Today

The Delhi High Court has called for recommendations from the Committee constituted by the Union Ministry of Ayush on determining the criteria by which raw materials used in the production of drugs can...

BUDGET EXPECTATIONS: The Indian pharmaceutical industry, also known as the pharma industry, commands a significant share in the global medicine supply chain and has played a pivotal role in making India the Pharmacy of the World. It is projected to reach USD 65 Bn by 2024. India ranks third in terms of volume but drops to 14th in terms of value.

Learn why it is crucial for doctors to specify the exact reason when prescribing antibiotics. Find out the government's initiative to prevent the misuse and overuse of antibiotics.

The Union Health Ministry has called for doctors to mention the indication and reason for prescribing antibiotics. This is in response to the misuse and overuse of antimicrobials, which contribute to the development of drug-resistant pathogens. The ministry emphasizes the importance of prudent antibiotic use to delay the emergence of resistance.

According to sources, Dr. Atul Goel, the Director General of Health Services, has appealed to all doctors in medical colleges to

The Bombay High Court on Wednesday admonished the State government, the appellate authority against drugs licence suspension orders, stating that a decision must not be kept pending for so long that...

The revised rules are expected to benefit companies focused on the domestic market. However, small companies may come under pressure because they may need a substantial capex to conform

A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers. While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies. The Schedule M of the Drugs and Cosmetics Rules specifies the good manufacturing practices (GMPs), which aim to ensure quality of drugs made in the country.

As online sales of substandard medicines surge, authorities face a daunting task in regulating and safeguarding public health. This was discussed during the pan-India chemist workshop held in Ahmedabad on Jan 7, which was attended by around 2,400 chemists from Ahmedabad and more than 34,000 chemists from around Gujarat.

One of the subsidiary company has received orders from Assistant Director & Drug Sales Licensing Authority, Drug Control administration from various locations.